. Author manuscript; available in PMC: 2010 Apr 1.

Published in final edited form as: Pharmacol Biochem Behav. 2009 Jan 10;92(2):319–326. doi: 10.1016/j.pbb.2008.12.020

Table 2.

Experiment 2: Summary of group names, numbers, and treatments.

Group Designation	Number of subjects	Conditioning						Extinction Phase
Group Designation	Number of subjects	Day 1	Day 2	Day 3	Day 4	Day 5	Day 6	Extinction Phase
**CTA+EXT**	4	SAC¹+LiCl²	Water	SAC +LiCl	Water	SAC +LiCl	Water	SAC
*(Mus)CTA⁴+EXT*	4	(Mus³)SAC +LiCl	Water	(Mus)SAC +LiCl	Water	(Mus)SAC +LiCl	Water	SAC
*CTA(Mus)⁵+EXT*	5	SAC(Mus)+LiCl	Water	SAC(Mus)+LiCl	Water	SAC(Mus)+LiCl	Water	SAC
*(Mus)CTA+ (Mus)EXT*⁶	6	(Mus)SAC +LiCl	Water	(Mus)SAC +LiCl	Water	(Mus)SAC+ LiCl	Water	(Mus)SAC

SAC = 0.3% saccharin salt solution

LiCl = lithium chloride solution (81mg/ml) prepared in physiological saline; administered at a dose of 81mg/kg, i.p.

Mus = muscimol injection (1mg/ml) prepared in physiological saline; administered a dose of 1mg/kg, i.p.

⁴

(Mus)CTA = muscimol was administered 30 min before SAC exposure throughout conditioning

⁵

CTA(Mus) = muscimol was administered 45 min after SAC exposure throughout conditioning

⁶

(Mus)CTA+(Mus)EXT = muscimol was administered before SAC exposure throughout conditioning and extinction